Name: Latest research reports of Alembic Pharmaceuticals Ltd. authored by Karvy and published by - Trendlyne research reports.
Item: Alembic Pharmaceuticals Ltd.
Rating: 3
Author: Karvy

Alembic Pharmaceuticals Ltd.

NSE: APLLTD | BSE: 533573 | ISIN: INE901L01018 | Industry: Pharmaceuticals
| Mid-range Performer

946.5000 -0.65 (-0.07%)

NSE Sep 12, 2025 15:31 PM

27.41% Fall from 52W High

Volume: 132.2K

Alembic Pharmaceuticals Ltd.

31 Jul 2019

946.50

-0.07%

Alembic Pharmaceuticals: Lower revenue growth due to muted performance in domestic formulations and ROW market

Hold: Alembic Pharmaceuticals Ltd.

Target

Karvy

In Q1FY20, total revenues of Alembic Pharma increased by 10% YoY to Rs 9.5 bn (below our estimates Rs 9.8 bn).

Alembic Pharmaceuticals Ltd. is trading below all available SMAs